by Brittany Scaturro | Sep 18, 2017 | Press Releases
Experienced pharmacologist, clinical scientist and senior regulatory leader brings new capabilities and expertise to growing clinical trials technology and service provider DURHAM, NORTH CAROLINA, September 18, 2017 – NeuroCog Trials (NCT), a clinical technology and... by Brittany Scaturro | Jul 13, 2017 | Publications and Articles
Innovative platform designed to deliver the highest quality of clinical data, streamline site processes, and improve patient experience DURHAM, NORTH CAROLINA, JULY 13, 2017 – NeuroCog Trials (NCT), a clinical technology and research services company dedicated... by Brittany Scaturro | Jul 11, 2017 | Publications and Articles
Questions: What is the magnitude of learning effects in patients with schizophrenia receiving placebo on the criterion standard Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB), and can these learning effects... by Brittany Scaturro | Apr 13, 2017 | Publications and Articles
Patients with psychotic disorders are often treated with numerous medications, many of which have anticholinergic activity. We assessed cognition in relation to the cumulative anticholinergic burden of multiple drugs included in treatment regimens of participants from... by Brittany Scaturro | Mar 17, 2017 | Posters
This poster was presented at the Annual Meeting of the American Society for Experimental NeuroTherapeutics (ASENT) 15-17 March 2017 Washington DC/Rockville MD Reliable measurement of functional capacity is critical in assessing the efficacy of treatments for...